Comparison between Gaudium IVF IPO and WeWork India IPO.
Gaudium IVF IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while WeWork India IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Gaudium IVF IPO is up to ₹165.00 Cr whereas the issue size of the WeWork India IPO is up to ₹3,000.00 Cr. The final issue price of Gaudium IVF IPO is ₹79.00 per share and of WeWork India IPO is ₹648.00 per share.
| Gaudium IVF IPO | WeWork India IPO | |
|---|---|---|
| Face Value | ₹5 per share | ₹10 per share |
| Issue Price (Lower) | ₹75.00 per share | ₹615.00 per share |
| Issue Price (Upper) | ₹79.00 per share | ₹648.00 per share |
| Issue Price (Final) | ₹79.00 per share | ₹648.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ₹60.00 per share | |
| Market Lot Size | 189 shares | 23 shares |
| Fresh Issue Size | 1,13,92,500 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹90.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 94,93,700 shares | 4,62,96,296 shares |
| OFS Issue Size (Amount) | up to ₹75.00 Cr | up to ₹3,000.00 Cr |
| Issue Size Total | 2,08,86,200 shares | 4,62,96,296 shares |
| Issue Size Total (Amount) | up to ₹165.00 Cr | up to ₹3,000.00 Cr |
Gaudium IVF IPO opens on Feb 20, 2026, while WeWork India IPO opens on Oct 03, 2025. The closing date of Gaudium IVF IPO and WeWork India IPO is Feb 24, 2026, and Oct 07, 2025, respectively.
| Gaudium IVF IPO | WeWork India IPO | |
|---|---|---|
| Anchor Bid Date | Feb 19, 2026 | Oct 01, 2025 |
| Issue Open | Feb 20, 2026 | Oct 03, 2025 |
| Issue Close | Feb 24, 2026 | Oct 07, 2025 |
| Basis Of Allotment (Tentative) | Feb 25, 2026 | Oct 08, 2025 |
| Initiation of Refunds (Tentative) | Feb 25, 2026 | Oct 09, 2025 |
| Credit of Share (Tentative) | Feb 26, 2026 | Oct 09, 2025 |
| Listing date (Tentative) | Feb 27, 2026 | Oct 10, 2025 |
| Anchor Lockin End date 1 | Mar 26, 2026 | Nov 06, 2025 |
| Anchor Lockin End date 2 | May 25, 2026 | Jan 05, 2026 |
Gaudium IVF IPO P/E ratio is 25.36, as compared to WeWork India IPO P/E ratio of 67.75.
| Gaudium IVF IPO | WeWork India IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated)WeWork India Management Ltd.'s revenue increased by 17% and profit after tax (PAT) rose by 194% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.99 | 73.56 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 71.30 | 48.07 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 25.36 | 67.75 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹575.02 Cr. | ₹8684.71 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 41.31% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 39.70% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.41 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹3.12 | ₹9.56 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 41.71% | 63.80% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Gaudium IVF IPO Retail Individual Investors (RII) are offered 73,10,170 shares while in WeWork India IPO retail investors are offered 73,10,170 shares. Qualified Institutional Buyers (QIB) are offered 41,77,240 shares in Gaudium IVF IPO and 1,38,71,033 shares in WeWork India IPO.
| Gaudium IVF IPO | WeWork India IPO | |
|---|---|---|
| Anchor Investor Reservation | 62,65,860 shares | 2,08,06,548 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 41,77,240 shares | 1,38,71,033 shares |
| NII | 31,32,930 shares | 69,35,515 shares |
| RII | 73,10,170 shares | 46,23,677 shares |
| Employee | 0 shares | 59,523 shares |
| Others | ||
| Total | 2,08,86,200 shares | 4,62,96,296 shares |
Gaudium IVF IPO subscribed 7.27x in total, whereas WeWork India IPO subscribed 1.15x.
| Gaudium IVF IPO | WeWork India IPO | |
|---|---|---|
| QIB (times) | 1.62x | 1.79x |
| NII (times) | 14.05x | 0.23x |
| Big NII (times) | 12.71x | 0.23x |
| Small NII (times) | 16.73x | 0.21x |
| RII (times) | 7.60x | 0.62x |
| Employee (times) | 1.87x | |
| Other (times) | ||
| Total (times) | 7.27x | 1.15x |
